Clinical trial
Observational Study on the Diagnosis and Management of Chronic Lymphocytic Leukemia (CLL) in Italy by Gruppo Italiano Malattie EMatologiche Dell'Adulto (GIMEMA)
NCT04867915 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study on the Diagnosis and Management of Chronic Lymphocytic Leukemia (CLL) in Italy by Gruppo Italiano Malattie EMatologiche Dell'Adulto (GIMEMA)
- Lead sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 13, 2021
- Completion date
- October 31, 2026
- Enrollment
- 12,500 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
chronic lymphocytic leukemia, mbl-cll - monoclonal b-cell lymphocytosis chronic lymphocytic leukaemia-type, small lymphocytic lymphoma